Trial Profile
A Phase I Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Dovitinib (Primary) ; Everolimus
- Indications Renal cell carcinoma
- Focus Adverse reactions
- Acronyms DEVELOP
- 01 Feb 2014 Results presented at the 2014 Genitourinary Cancers Symposium.
- 21 Nov 2012 New trial record